Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001339278 | SCV001533011 | uncertain significance | Cohen syndrome | 2020-04-14 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals with VPS13B-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available"). This variant is present in population databases (rs758694590, ExAC 0.002%). This sequence change replaces asparagine with lysine at codon 2435 of the VPS13B protein (p.Asn2435Lys). The asparagine residue is moderately conserved and there is a moderate physicochemical difference between asparagine and lysine. |
Natera, |
RCV001339278 | SCV002082641 | uncertain significance | Cohen syndrome | 2020-04-28 | no assertion criteria provided | clinical testing |